Clinical Trial Update: A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (ARTEMIS) evaluating the efficacy of AGA2118 in postmenopausal osteoporosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• AGA2118

Snippet

Sponsor: Angitia Biopharmaceuticals | Conditions: Postmenopausal Osteoporosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING